KMT2A and acute lymphoblastic leukemia: It was demonstrated that tr-ALL imparts more severe outcomes compared to de novo ALL (dn-ALL), and some characteristic mutations of tr-ALL, including KMT2A (MLL) rearrangements, have been reported at a relatively high frequency 4.